MAPT and Alzheimer disease: The lack of significant differences between individuals harboring only AD pathology and those harboring additional pathologies suggest that these additional pathologies may not modify NDEV A/T/N cargo although biomarkers capturing these additional pathologies might, suggesting an additive effect to that of Aβ and Tau.